Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathilde Hunault

Showing results (81-90 of 129) with videos related to

Pageof 13
Sort By:
Cancer Medicine|August 24, 2021
Improved survival with enasidenib versus standard of care in relapsed/refractory acute myeloid leukemia associated with IDH2 mutations using historical data and propensity score matching analysisStéphane de Botton, Joseph M Brandwein, Andrew H Wei, et al.
Blood|August 12, 2009
TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs)Olivier Kosmider, Véronique Gelsi-Boyer, Meyling Cheok, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2017
Addition of Androgens Improves Survival in Elderly Patients With Acute Myeloid Leukemia: A GOELAMS StudyArnaud Pigneux, Marie C Béné, Philippe Guardiola, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 5, 2018
Intensified Therapy of Acute Lymphoblastic Leukemia in Adults: Report of the Randomized GRAALL-2005 Clinical TrialFrançoise Huguet, Sylvie Chevret, Thibaut Leguay, et al.
Annals of Hematology|April 11, 2023
Outcome of patients with newly diagnosed AML admitted to the ICU, including preemptive admission - a multi-center studyChristophe Desprez, Achille Kouatchet, Tony Marchand, et al.
Blood|August 10, 2017
Impact of cytogenetic abnormalities in adults with Ph-negative B-cell precursor acute lymphoblastic leukemiaMarina Lafage-Pochitaloff, Laurence Baranger, Mathilde Hunault, et al.
Haematologica|October 3, 2015
Nodular lymphocyte predominant Hodgkin lymphoma: a Lymphoma Study Association retrospective studyJulien Lazarovici, Peggy Dartigues, Pauline Brice, et al.
Blood Advances|October 17, 2024
Midostaurin shapes macroclonal and microclonal evolution of FLT3-mutated acute myeloid leukemiaRomane Joudinaud, Augustin Boudry, Laurène Fenwarth, et al.
Blood|July 17, 2004
Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow transplantation (BMT) than after late high-dose therapy and autologous BMT: a GOELAMS trialMathilde Hunault, Jean-Luc Harousseau, Martine Delain, et al.
British Journal of Haematology|November 12, 2019
Sequential mutational evaluation of CALR -mutated myeloproliferative neoplasms with thrombocytosis reveals an association between CALR allele burden evolution and disease progressionLaurane Cottin, Jérémie Riou, Corentin Orvain, et al.
Pageof 13

Showing results (81-90 of 129) with videos related to

Sort By:
Pageof 13
Cancer Medicine|August 24, 2021
Improved survival with enasidenib versus standard of care in relapsed/refractory acute myeloid leukemia associated with IDH2 mutations using historical data and propensity score matching analysisStéphane de Botton, Joseph M Brandwein, Andrew H Wei, et al.
Blood|August 12, 2009
TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs)Olivier Kosmider, Véronique Gelsi-Boyer, Meyling Cheok, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2017
Addition of Androgens Improves Survival in Elderly Patients With Acute Myeloid Leukemia: A GOELAMS StudyArnaud Pigneux, Marie C Béné, Philippe Guardiola, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 5, 2018
Intensified Therapy of Acute Lymphoblastic Leukemia in Adults: Report of the Randomized GRAALL-2005 Clinical TrialFrançoise Huguet, Sylvie Chevret, Thibaut Leguay, et al.
Annals of Hematology|April 11, 2023
Outcome of patients with newly diagnosed AML admitted to the ICU, including preemptive admission - a multi-center studyChristophe Desprez, Achille Kouatchet, Tony Marchand, et al.
Blood|August 10, 2017
Impact of cytogenetic abnormalities in adults with Ph-negative B-cell precursor acute lymphoblastic leukemiaMarina Lafage-Pochitaloff, Laurence Baranger, Mathilde Hunault, et al.
Haematologica|October 3, 2015
Nodular lymphocyte predominant Hodgkin lymphoma: a Lymphoma Study Association retrospective studyJulien Lazarovici, Peggy Dartigues, Pauline Brice, et al.
Blood Advances|October 17, 2024
Midostaurin shapes macroclonal and microclonal evolution of FLT3-mutated acute myeloid leukemiaRomane Joudinaud, Augustin Boudry, Laurène Fenwarth, et al.
Blood|July 17, 2004
Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow transplantation (BMT) than after late high-dose therapy and autologous BMT: a GOELAMS trialMathilde Hunault, Jean-Luc Harousseau, Martine Delain, et al.
British Journal of Haematology|November 12, 2019
Sequential mutational evaluation of CALR -mutated myeloproliferative neoplasms with thrombocytosis reveals an association between CALR allele burden evolution and disease progressionLaurane Cottin, Jérémie Riou, Corentin Orvain, et al.
Pageof 13